• Balance Labs posted a net loss of $236,841 for the quarter ended June 30, 2026, widening from a net loss of $146,142.
• Revenue was $7,333, versus no revenue a year earlier, as an advisory engagement concluded and was invoiced and collected.
• Operating expenses climbed to $507,890 from $79,259, driven by salaries and wages of $463,835 including $332,810 in stock-based compensation.
• Other income swung to $263,716 from an expense of $66,883 on a $276,449 gain from remeasuring a derivative liability.
• Cash was $117,465 at June 30, 2026; working capital deficit improved to $2.77 million from $3.38 million at Dec. 31, 2025.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Balance Labs Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-038265), on August 14, 2026, and is solely responsible for the information contained therein.